Traws Pharma, Inc. Shareholders' Equity
Traws Pharma, Inc. (TRAW) had Shareholders' Equity of $11.57 million as of 2019-12-31, per its 10-K filed 2020-03-27.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquity · last filed 2020-03-27
- 2019-12-31: Stockholders' Equity Attributable to Parent $11.57M.
- 2019-09-30: Stockholders' Equity Attributable to Parent -$6.04M.
- 2019-06-30: Stockholders' Equity Attributable to Parent -$4.55M.
- 2019-03-31: Stockholders' Equity Attributable to Parent -$1.54M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2019-12-31 | $11.57M 10-K · filed 2020-03-27 |
| 2019-09-30 | -$6.04M 10-Q · filed 2019-11-12 |
| 2019-06-30 | -$4.55M 10-Q · filed 2019-08-14 |
| 2019-03-31 | -$1.54M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $5.39M 10-K · filed 2020-03-27 |
| 2018-09-30 | $10.86M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $15.91M 10-Q · filed 2018-08-14 |
| 2018-03-31 | -$7.71M 10-Q · filed 2018-05-15 |
| 2017-12-31 | -$11.69M 10-K · filed 2019-04-01 |
| 2017-09-30 | -$6.91M 10-Q · filed 2017-11-09 |
| 2017-06-30 | -$388.00K 10-Q · filed 2017-08-14 |
| 2017-03-31 | -$3.54M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $4.30M 10-K · filed 2018-03-16 |
| 2016-09-30 | $9.19M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $1.22M 10-Q · filed 2016-08-15 |
| 2016-03-31 | $5.99M 10-Q · filed 2016-05-11 |
| 2015-12-31 | $10.01M 10-K · filed 2017-03-29 |
| 2015-09-30 | $3.37M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $3.75M 10-Q · filed 2015-08-13 |
| 2015-03-31 | $11.76M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $22.75M 10-K · filed 2016-03-28 |
| 2014-09-30 | $35.27M 10-Q · filed 2014-11-14 |
| 2014-06-30 | $48.52M 10-Q · filed 2014-08-14 |
| 2014-03-31 | $63.91M 10-Q · filed 2014-05-15 |
| 2013-12-31 | $80.41M 10-K · filed 2015-03-30 |
| 2013-09-30 | $93.83M 10-Q · filed 2013-11-14 |
| 2013-06-30 | -$172.94M 10-Q · filed 2013-09-06 |
| 2012-12-31 | -$158.31M 10-K · filed 2014-03-20 |
| 2012-09-30 | -$152.63M 10-Q · filed 2013-11-14 |
| 2012-06-30 | -$158.75M 10-Q · filed 2013-09-06 |
| 2011-12-31 | -$138.42M 10-Q · filed 2013-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |